Brain Perivascular Macrophages and the Sympathetic Response to Inflammation in Rats After Myocardial Infarction

Inflammation is associated with increased sympathetic drive in cardiovascular diseases. Blood-borne proinflammatory cytokines, markers of inflammation, induce cyclooxygenase 2 (COX-2) activity in perivascular macrophages of the blood-brain barrier. COX-2 generates prostaglandin E2, which may enter the brain and increase sympathetic nerve activity. We examined the contribution of this mechanism to augmented sympathetic drive in rats after myocardial infarction (MI). Approximately 24 hours after acute MI, rats received an intracerebroventricular injection (1 &mgr;L/min over 40 minutes) of clodronate liposomes (MI+CLOD) to eliminate brain perivascular macrophages, liposomes alone, or artificial cerebrospinal fluid. A week later, COX-2 immunoreactivity in perivascular macrophages and COX-2 mRNA and protein had increased in hypothalamic paraventricular nucleus of MI rats treated with artificial cerebrospinal fluid or liposomes alone compared with sham-operated rats. In MI+CLOD rats, neither perivascular macrophages nor COX-2 immunoreactivity was seen in the paraventricular nucleus, and COX-2 mRNA and protein levels were similar to those in sham-operated rats. Prostaglandin E2 in cerebrospinal fluid, paraventricular nucleus neuronal excitation, and plasma norepinephrine were less in MI+CLOD rats than in MI rats treated with artificial cerebrospinal fluid or liposomes alone but more than in sham-operated rats. Intracerebroventricular CLOD had no effect on interleukin 1β and tumor necrosis factor-α mRNA and protein in the paraventricular nucleus or plasma interleukin-1β and tumor necrosis factor-α, which were increased in MI compared with sham-operated rats. In normal rats, pretreatment with intracerebroventricular CLOD reduced (P<0.05) the renal sympathetic, blood pressure, and heart rate responses to intracarotid artery injection of tumor necrosis factor-α (0.5 &mgr;g/kg); intracerebroventricular liposomes had no effect. The results suggest that proinflammatory cytokines stimulate sympathetic excitation after MI by inducing COX-2 activity and prostaglandin E2 production in perivascular macrophages of the blood-brain barrier.

[1]  R. Weiss,et al.  Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure , 2006, Circulation Research.

[2]  R. Weiss,et al.  Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.

[3]  Z.-H. Zhang,et al.  Pharmacological Treatment for Heart Failure: A View From the Brain , 2009, Clinical pharmacology and therapeutics.

[4]  R. Weiss,et al.  Progression of heart failure after myocardial infarction in the rat. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  F. Leenen,et al.  Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade. , 2007, Journal of molecular and cellular cardiology.

[6]  C. Eder.  Regulation of microglial behavior by ion channel activity , 2005, Journal of neuroscience research.

[7]  G. Dibona.  Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. , 2000, Hypertension.

[8]  R. Dringen.  Oxidative and antioxidative potential of brain microglial cells. , 2005, Antioxidants & redox signaling.

[9]  R. Weiss,et al.  Acute myocardial infarction induces hypothalamic cytokine synthesis. , 2004, American journal of physiology. Heart and circulatory physiology.

[10]  K. Patel,et al.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. , 2003, Acta physiologica Scandinavica.

[11]  R. Adan,et al.  Hypothalamic neuropeptide expression following chronic food restriction in sedentary and wheel-running rats. , 2005, Journal of molecular endocrinology.

[12]  F. Leenen,et al.  Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. , 2005, American journal of physiology. Heart and circulatory physiology.

[13]  M. Block,et al.  Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.

[14]  J. Francis,et al.  Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. , 2008, Cardiovascular research.

[15]  F. Fan,et al.  Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ , 2004, Journal of neuroscience research.

[16]  C. W. Greene.  THE AMERICAN PHYSIOLOGICAL SOCIETY. , 1922, Science.

[17]  R. Felder.  Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure , 2010, Experimental physiology.

[18]  J. Francis,et al.  Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  P. Sawchenko,et al.  Signaling the brain in systemic inflammation: the role of perivascular cells. , 2003, Frontiers in bioscience : a journal and virtual library.

[20]  P. H. Goede,et al.  A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system , 2001, Journal of Neuroimmunology.

[21]  R. Weiss,et al.  Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.

[22]  R. Weiss,et al.  Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. , 2008, American journal of physiology. Heart and circulatory physiology.

[23]  S. Oparil,et al.  The sympathetic nervous system in clinical and experimental hypertension. , 1986, Kidney international.

[24]  E. Vizi,et al.  Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.

[25]  P. Perin,et al.  SYMPATHETIC NERVOUS SYSTEM, DIABETES, AND HYPERTENSION , 2001, Clinical and experimental hypertension.

[26]  D. Feldman,et al.  Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure , 2005, Nature Clinical Practice Cardiovascular Medicine.

[27]  R. Weiss,et al.  Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure? , 2008, Hypertension.

[28]  R. Weiss,et al.  Heart failure and the brain: new perspectives. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  Guiding principles for research involving animals and human beings. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[30]  A. Pol.  The magnocellular and parvocellular paraventricular nucleus of rat: Intrinsic organization , 1982 .

[31]  D. Dewitt,et al.  Characterization of inducible cyclooxygenase in rat brain , 1995, The Journal of comparative neurology.

[32]  S. Rivest.  How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis , 2001, Psychoneuroendocrinology.

[33]  R. Weiss,et al.  Increased Cyclooxygenase-2 Expression in Hypothalamic Paraventricular Nucleus in Rats With Heart Failure: Role of Nuclear Factor &kgr;B , 2007, Hypertension.

[34]  Yao Sun.  Myocardial repair/remodelling following infarction: roles of local factors. , 2008, Cardiovascular research.

[35]  A. N. van den Pol.  The magnocellular and parvocellular paraventricular nucleus of rat: Intrinsic organization , 1982, The Journal of comparative neurology.

[36]  N. Van Rooijen,et al.  Kupffer cell depletion by liposome‐delivered drugs: Comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid , 1996, Hepatology.

[37]  A. Dunn.  Cytokine Activation of the HPA Axis , 2000, Annals of the New York Academy of Sciences.

[38]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[39]  J. Granger.  An emerging role for inflammatory cytokines in hypertension. , 2006, American journal of physiology. Heart and circulatory physiology.

[40]  M. Esler,et al.  Mediators of sympathetic activation in metabolic syndrome obesity , 2008, Current hypertension reports.

[41]  P. Sawchenko,et al.  CNS activational responses to staphylococcal enterotoxin B: T‐lymphocyte‐dependent immune challenge effects on stress‐related circuitry , 2006, The Journal of comparative neurology.

[42]  R. Weiss,et al.  Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.

[43]  Yu-Ming Kang,et al.  Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. , 2008, American journal of physiology. Heart and circulatory physiology.

[44]  P. Sawchenko,et al.  Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults , 2002, The Journal of Neuroscience.

[45]  M. Raizada,et al.  Brain cytokines as neuromodulators in cardiovascular control , 2010, Clinical and experimental pharmacology & physiology.

[46]  R. Weiss,et al.  Central Gene Transfer of Interleukin-10 Reduces Hypothalamic Inflammation and Evidence of Heart Failure in Rats After Myocardial Infarction , 2007, Circulation research.